Optimising experimental research in respiratory diseases: an ERS statement

P. Bonniaud, A. Fabre, N. Frossard, et al.

Source: Guideline 2018
Number: 2018

PDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
P. Bonniaud, A. Fabre, N. Frossard, et al.. Optimising experimental research in respiratory diseases: an ERS statement. Guideline 2018

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.

Related content which might interest you:
Optimizing experimental research in respiratory diseases: an ERS Statement
Source: International Congress 2018 – Organoids and pluripotent stem cells
Year: 2018

Quality assessment of clinical practice guidelines for respiratory diseases in China: A systematic appraisal
Source: International Congress 2015 – Healthcare organisation and appropriateness in lung disorders
Year: 2015

The quality of evidence-based clinical practice guidelines for chronic respiratory diseases could be improved: An observational study
Source: International Congress 2016 – Treatment and assessment of functional outcomes in cardiorespiratory physiotherapy
Year: 2016

Tackling the heart sink symptom: ERS guidelines on chronic cough
Source: ISSN=ISSN 1810-6838, ISBN=, page=89
Year: 2004

H2020 funding for respiratory research: scaling up for the prevention and treatment of lung diseases
Source: Eur Respir J, 54 (3) 1901417; 10.1183/13993003.01417-2019
Year: 2019

ERS statement on standardisation of cardiopulmonary exercise testing in chronic lung diseases
Source: Eur Respir Rev, 28 (154) 180101; 10.1183/16000617.0101-2018
Year: 2019

The importance of real-life research in respiratory medicine: manifesto of the Respiratory Effectiveness Group
Source: Eur Respir J, 54 (3) 1901511; 10.1183/13993003.01511-2019
Year: 2019

Translating research into practice: how are guidelines implemented?
Source: Eur Respir J 2003; 21: 23S-29S
Year: 2003

Implementation of personalized treatment of asthma by improved phenotyping: Critical review of knowledge gaps and unmet research needs by the European asthma research & innovation partnership (EARIP) expert panel
Source: International Congress 2016 – Phenotyping asthma
Year: 2016

Respiratory care in different situations: an overview of the epidemiology of respiratory diseases and their (co)morbidity
Source: Virtual Congress 2020 – Part II: From symptoms to diagnosis in primary care
Year: 2020

The ERS perspective on respiratory medicine research
Source: ERS Course 2015
Year: 2015

Global survey of the physiotherapy management of infants with CF as a basis for the development of international guidelines - an ERS taskforce project endorsed by the IPG/CF
Source: Eur Respir J 2001; 18: Suppl. 33, 301s
Year: 2001

The new WHO air quality guidelines: policy and clinical implications for children with respiratory diseases
Source: Virtual Congress 2021 – The environment and climate change effects on lung health across the lifecourse
Year: 2021

ERS/EAACI statement on severe exacerbations in asthma in adults: facts, priorities and key research questions
Source: Guideline 2019
Year: 2019

ATS/ERS Statement on occupational burden of respiratory disease
Source: International Congress 2019 – Occupational and epidemiology Grand Round
Year: 2019

ERS position paper: work-related respiratory diseases in the EU
Source: Eur Respir J 2010; 35: 234-238
Year: 2010

Consultation on basic asthma research strategy
Source: Eur Respir J 2002; 20: 795-796
Year: 2002

Cough clinical practice guidelines: A critical review of scientific evidence and recommendations
Source: International Congress 2016 – Epidemiological and clinical data regarding the modern management of chronic lung diseases
Year: 2016

International research outputs and funding in respiratory medicine
Source: Eur Respir J 2003; 22: Suppl. 45, 484s
Year: 2003

Tailoring the approach to multimorbidity in adults with respiratory disease: the NICE guideline
Source: Eur Respir J , 49 (2) 1601696; DOI: 10.1183/13993003.01696-2016
Year: 2017